Hanson McClain Advisors »

Theravance Biopharma shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0k 178 11.24
2023-09-30 $112 13 8.69
2023-06-30 $1.1k 106 10.36
2023-03-31 $1.2k 106 10.86
2022-03-31 $11k 1.1k 9.73
2021-12-31 $12k 1.1k 10.62